Safety and efficacy of nilotinib in patients with chronic myeloid leukemia: A phase II study

Trial Profile

Safety and efficacy of nilotinib in patients with chronic myeloid leukemia: A phase II study

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Nilotinib (Primary)
  • Indications Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Acronyms Step Stop trial
  • Most Recent Events

    • 30 Aug 2016 New trial record
    • 01 Aug 2015 Recruitment completed, according to results presented at the 21st Congress of the European Haematology Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top